ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > gp130

gp130

概要

Name:Interleukin-6 receptor subunit beta
Target Synonym:IL6ST,Oncostatin-M Receptor Subunit Alpha,CD130,Interleukin-6 Signal Transducer,Interleukin-6 Receptor Subunit Beta,Gp130 Of The Rheumatoid Arthritis Antigenic Peptide-Bearing Soluble Form,CD130 Antigen,Membrane Glycoprotein Gp130,SGP130,IL-6R-Beta,HIES4,Gp130, Oncostatin M Receptor,IL-6RB,GP130,Cytokine Receptor gp130,Interleukin 6 Signal Transducer,Membrane Glycoprotein 130,Interleukin 6 Signal Transducer (Gp130, Oncostatin M Receptor),CDW130,IL-6 Receptor Subunit Beta,Interleukin Receptor Bet
Number of Launched Drugs:6
Number of Drugs in Clinical Trials:12
Lastest Research Phase:Approved

製品リスト製品比較と製品注文

ACRO Quality

生物活性データの一部

ILT-H52H2-MALS-HPLC
gp130 MALS images

The purity of Human gp130, His Tag (Cat. No. ILT-H52H2) is more than 90% and the molecular weight of this protein is around 85-105kDa verified by SEC-MALS.

ILT-H52H2-ELISA
 gp130 ELISA

Immobilized Biotinylated Human IL-6 R alpha, Fc,Avitag (Cat. No. ILR-H82F9) at 10 μg/mL (100 μL/well) can bind Human gp130, His Tag (Cat. No. ILT-H52H2) with a linear range of 0.005-0.313 μg/mL (QC tested).

Synonym Name

IL6ST,gp130,CD130,IL-6RB,IL-6R-beta,CDw130

Background

Interleukin-6 receptor subunit beta (IL6ST) is also known as IL-6 receptor subunit beta, IL-6R subunit beta, IL-6R-beta, IL-6RB, Interleukin-6 signal transducer, Membrane glycoprotein 130 (gp130), CD130, Oncostatin-M receptor subunit alpha and Il6st,which is single-pass type I membrane protein. IL6ST /gp130 /CD130 can be found in tissues such as brain, heart, thymus, spleen, kidney, lung and liver and found in all the cell lines tested except BaF-B03.The expression of IL-6ST /gp130 is not restricted to IL6-responsive cells. The receptor systems for IL6, LIF, OSM, CNTF, IL11, CTF1 and BSF3 can utilize gp130 for initiating signal transmission. IL6ST /CD130 can bind to IL6 /IL6R (alpha chain) complex, resulting in the formation of high-affinity IL6 binding sites, and transduce the signal. IL6ST /GP130 does not bind IL6 and may have a role in embryonic development.

Clinical and Translational Updates

公開薬物情報

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Tocilizumab biosimilar (Livzon Group) LZM-008 Approved Livzon Pharmaceutical Group Inc 安维泰 Mainland China Arthritis, Rheumatoid Livzon Mabpharm Inc 2023-01-18 Arthritis, Rheumatoid Details
Tocilizumab biosimilar (Bio-Thera Solutions) BAT-1806; BIIB-800 Approved Bio-Thera Solutions Ltd 施瑞立, TOFIDENCE Mainland China Arthritis, Rheumatoid; Arthritis, Juvenile; Cytokine Release Syndrome Bio-Thera Solutions Ltd 2023-01-16 Cytokine Release Syndrome; Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Arthritis, Juvenile Details
Satralizumab RG-6168; SA-237 Approved Chugai Pharmaceutical Co Ltd Enspryng, エンスプリング Japan Neuromyelitis Optica Chugai Pharmaceutical Co Ltd 2020-06-29 Myasthenia Gravis; Brain Ischemia; Graves Ophthalmopathy; Neuromyelitis Optica; Pulmonary Arterial Hypertension; Encephalitis; Subarachnoid Hemorrhage; Anti-N-Methyl-D-Aspartate Receptor Encephalitis Details
Tocilizumab biosimilar (Fresenius kabi) MSB-11456 Approved Merck Serono EU Cytokine Release Syndrome; Arthritis, Rheumatoid; Giant Cell Arteritis Fresenius Kabi Deutschland Gmbh 2023-09-15 Cytokine Release Syndrome; Giant Cell Arteritis; Arthritis, Rheumatoid Details
Tocilizumab MRA; HPM-1; MRA-SC; R-1569; rhPM-1; RG-1569; RO-48775533 Approved Chugai Pharmaceutical Co Ltd Actemra/RoActemra, 雅美罗, Actemra, RoActemra Japan Arthritis, Juvenile; Arthritis, Rheumatoid; Giant Cell Arteritis; Takayasu Arteritis; Cytokine Release Syndrome; Multicentric Castleman's Disease (MCD) null 2005-04-11 Uveitis; Respiratory Distress Syndrome, Adult; systemic sclerosis-associated interstitial lung disease; Lupus Erythematosus, Systemic; Coronavirus Infections; Pulmonary Arterial Hypertension; Takayasu Arteritis; Coronary Disease; Multicentric Castleman's Disease (MCD); Breast Neoplasms; Coronaviridae Infections; Fever; Pleural Effusion, Malignant; Pulmonary Disease, Chronic Obstructive; Polymyalgia Rheumatica; Osteoarthritis; Inflammation; Uveitis, Posterior; Lymphoma; Rejection in heart transplantation; Non-ST Elevated Myocardial Infarction; Anemia, Sickle Cell; Kidney Failure, Chronic; Diabetes Mellitus; Behcet Syndrome; Amyotrophic Lateral Sclerosis; Panuveitis; Carcinoma, Hepatocellular; Myocardial Infarction; Cytokine Release Syndrome; Non-radiographic axial spondyloarthritis; Craniopharyngioma; Motor Neuron Disease; Polymyositis; Diabetes Mellitus, Type 1; Hematologic Neoplasms; Solid tumours; HIV Infections; Polyarticular Juvenile Idiopathic Arthritis; Dermatomyositis; Giant Cell Arteritis; Schnitzler Details
Sarilumab REGN-88; SAR-153191 Approved Sanofi, Regeneron Pharmaceuticals Inc Kevzara United States Arthritis, Rheumatoid Sanofi-Synthelabo 2017-05-22 Non-radiographic axial spondyloarthritis; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Mastocytosis, Systemic; Sarcoidosis; Polymyalgia Rheumatica; Arthritis, Juvenile; Severe Acute Respiratory Syndrome; Uveitis Details

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
VDJ-001 Phase 2 Clinical Beijing Vdjbio Co Ltd Arthritis, Rheumatoid; Multicentric Castleman's Disease (MCD) Details
Tocilizumab Biosimilar (qyuns) QX-003-S Phase 1 Clinical Qyuns Therapeutics Co Ltd Arthritis, Rheumatoid Details
Tocilizumab biosimilar (Celltrion) CT-P47; CT-P-47 Phase 3 Clinical Celltrion Inc Arthritis, Rheumatoid Details
Tocilizumab biosimilar (AryoGen Pharmed) Phase 3 Clinical Aryogen Biopharma Arthritis, Rheumatoid Details
Recombinant humanized anti-IL-6R antibody (Hisun Pharma) HS-628 Phase 3 Clinical Zhejiang Hisun Pharmaceutical Co Ltd Arthritis, Rheumatoid; Arthritis Details
CMAB806 CMAB-806 Phase 3 Clinical Taizhou Maibo Taike Biotechnology Co Ltd Arthritis, Rheumatoid; Arthritis Details
Levilimab BCD-089 Phase 3 Clinical Biocad Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19) Details
Atexakin alfa SON-080; r-IL-6 Phase 2 Clinical Merck Serono, Weizmann Institute Of Science Peripheral Nervous System Diseases; Diabetic Neuropathies Details
Olamkicept FE-999301; CR-5/18; TJ-301; FE-301 Phase 2 Clinical Conaris Research Institute Colitis, Ulcerative Details

This web search service is supported by Google Inc.

totopphone